J M Lippitt

Zoledronic Acid Treatment of 5T2MM-Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

Peter I. Croucher, Hendrik De Raeve, Mark Perry et al. · Journal of Bone and Mineral Research · 2003 · 267 citations · Full text

Medicine, Oncology, Pharmacology +17

Colonic Dendritic Cells, Intestinal Inflammation, and T Cell-Mediated Bone Destruction Are Modulated by Recombinant Osteoprotegerin

A. John Ashcroft, Sheena Cruickshank, Peter I. Croucher et al. · Immunity · 2003 · 184 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo – A Role in Tumour Cell Survival?

Ingunn Holen, Simon S. Cross, Helen Neville-Webbe et al. · Breast Cancer Research and Treatment · 2005 · 125 citations

Medicine, Cell Biology, Oncology +11

Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables

Simon S. Cross, Robert F. Harrison, Sabapathy P. Balasubramanian et al. · Journal of Clinical Pathology · 2006 · 63 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Trihalomethanes as initiators and promoters of carcinogenesis.

Michael A. Pereira, Lianbing Lin, J M Lippitt et al. · Environmental Health Perspectives · 1982 · 42 citations · Full text

Pharmacy, Toxicology, Carcinogenesis +12